Keiretsu Forum Mid-Atlantic, South-East, and Texas regions are proud to announce their sponsorship of TibaRay, LLC at the upcoming Innovation Funders Showcase during the 2024 Angel Capital Association (ACA) Summit. This initiative aligns with Keiretsu Forum's commitment to advancing innovative medical technologies that promise to transform patient care on a global scale.
Revolutionizing Cancer Radiation Therapy
TibaRay is set to redefine cancer treatment through its pioneering advancements in radiation therapy technology. With the introduction of the PHASER system, TibaRay offers instantaneous treatment that is 400 times faster than traditional methods, combined with motion-freezing precision and real-time diagnostic-quality CT image-guidance. This leap in technology marks the most significant advancement in the field in over six decades.
Harnessing the FLASH Effect for Superior Outcomes
The core of TibaRay's innovation is the FLASH effect, an advantageous biological response to ultra-fast radiation that achieves equal or better tumor-killing efficacy with significantly less damage to surrounding healthy tissue. This method allows for a more precise and safer dose of radiation, effectively reducing the risks associated with traditional radiation therapy.
Powered by Groundbreaking Inventions
TibaRay's technology is backed by novel linear accelerators and RF sources developed through breakthroughs in accelerator science by world-renowned experts from Stanford and the SLAC National Accelerator Lab. These innovations make TibaRay's systems not only more efficient and compact but also more economically viable to manufacture, positioning TibaRay for widespread adoption and success.
About TibaRay
TibaRay's mission is to bring the hope of a cure to patients with all types and stages of cancer worldwide. As a StartX company, TibaRay is part of a community of serial entrepreneurs, industry experts, and tenured professors, striving to transform cancer therapy with their unique eXactFLASHTM technology and a new class of radiation treatment devices.
About Keiretsu Forum Mid-Atlantic, South-East, and Texas
Keiretsu Forum is the world’s largest private equity angel investment network, with over 2,000 accredited investors across 34 North American and 23 International chapters. They have invested more than $1 billion in a variety of sectors, including technology, life sciences, and consumer products, over the last 23 years.
The ACA Summit, set to take place in Columbus, Ohio from May 13-15, 2024, will serve as a vital platform for networking, innovation, and investment opportunities in the healthcare sector.
For more information on the ACA Summit and TibaRay's participation, please contact:
Cindi Sutera
AMS Communications
cindis@amscommunications.net
610-613-2773